Hepatocellular carcinoma (HCC) is one of the most common cancers in many parts of the world, however the molecular mechanisms underlying liver cell transformation remain obscure. A genome-wide scan of loss of heterozygosity (LOH) in tumors provides a powerful tool to search for genes involved in neoplastic processes. To identify recurrent genetic alterations in liver tumors, we examined DNAs isolated from 120 HCCs and their adjacent non tumorous parts for LOH using a collection of 195 microsatellite markers located roughly every 20 cM throughout 39 autosomal arms. The mean heterozygosity was 73%. Our ®ndings provide additional support that LOH for loci on chromosomal arms 1p, 4q, 6q, 8p, 13q and 16p is signi®cantly elevated in HCC. The highest percentage of LOH is found for a locus in 8p23 (42% of informative csaes). This corresponds to one of the most common genetic abnormalities reported to date in these tumors. In addition, high ratio of LOH (535%) is observed on chromosome arms which had not been implicated in previous studies, notably on 1q, 2q and 9q. No correlation was found between LOH of speci®c chromosomal regions and etiologic factors such as chronic infections with hepatitis B or C viruses. This ®rst report of an extensive allelotypic analysis of HCC should help in identifying new genes whose loss of function contributes to the development of liver cancer.
Introduction
The development of human cancers results from clonal expansion of genetically modi®ed cells that acquired selective growth advantage through accumulated alterations of proto-oncogenes and tumor suppressor genes (for review see Weinberg, 1991) . Somatic inactivation of tumor suppressor genes is usually achieved by intragenic mutations in one allele of the gene and by the loss of a chromosomal region spanning the second allele. Chromosomal analysis using polymorphic DNA markers that distinguish dierent alleles has revealed loss of heterozygosity (LOH) of speci®c chromosomal regions in various types of cancers and the mapping of regions with a high frequency of LOH has been critical for identifying negative regulators of tumor growth (Call et al., 1990; Fearon et al., 1990; Friend et al., 1986) . The recent development of microsatellite polymorphic markers has allowed positional cloning of several tumor suppressor genes such as the BRCA1, BRCA2 and DPC4 genes (Hahn et al., 1996; Miki et al., 1994; Wooster et al., 1995) .
Primary liver cancer of HCC is a leading cause of death in many countries of the world. Epidemiological evidence has shown the predominant role of hepatitis B virus (HBV) as a major causal agent of liver cancer. Other risk factors include chronic infection with hepatitis C virus (HCV), alcohol abuse, environmental exposure to hepatocarcinogens such as a¯atoxin B1, and several genetic diseases (reviewed in Buendia and Pineau, 1995) . However, the role of hepatotropic viral agents and the molecular events leading to liver carcinogenesis remain unknown. A mutagenic role of HBV DNA integration in the host genome, that occurs frequently at early stages of HBV-associated tumorigenesis, was conclusively established only in rare cases (Dejean et al., 1986; Wang et al., 1990) , suggesting more indirect transformation pathways (Matsubara, 1991) . A common feature in chronic viral hepatitis and liver cirrhosis is long lasting in¯ammation of the liver associated with chronic regenerative conditions, which might enhance the susceptibility of liver cells to genetic changes.
Previous studies, mainly relying upon either restriction fragment length polymorphism (RFLP) markers or microsatellite markers restricted to speci®c chromosome arms, have de®ned a number of recurring chromosomal regions of LOH in liver cancer. One of the most frequent allelic deletions in HCC has been found at chromosome 17p where the tumor suppressor gene p53 is located (Fujimori et al., 1991; Murakami et al., 1991; Slagle et al., 1991) . The frequency of p53 mutations varies largely among HCC samples, depending on the geographic location in the world, and a hot spot mutation at codon 249 was observed in HCCs from regions with high levels of dietary a¯atoxins and high prevalence of HBV infection (Bressac et al., 1991; Buetow et al., 1992; Hsu et al., 1991) . Regional deletions spanning the RB locus on chromosome 13q have also been described, but in this case, a low mutation rate was found in the remaining allele (Murakami et al., 1991; Wang and Rogler, 1988; Zhang et al., 1994) . Other frequent LOH was reported on chromosome arms 1p, 4q, 5q, 6q, 8p, 10q, 11p, 16p, 16q and 22q (Buetow et al., 1989; De Souza et al., 1995; Emi et al., 1992; Fujimori et al., 1991; Takahashi et al., 1993; Tsuda et al., 1990; Wang and Rogler, 1988; Yeh et al., 1994) . Candidate tumor suppressor genes in these regions include the mannose 6-phosphate/insulin-like growth factor II receptor gene (M6P/IGF2R) on 6q26 ± q27 (De Souza et al., 1995) , the PDGF-receptor beta-like tumor suppressor gene (PRLTS) on 8p21-p22 and the E-Cadherin gene on 16q22 (Slagle et al., 1993) .
In this study, we performed a systematic screening of 120 HCC samples using 195 highly polymorphic microsatellite markers evenly distributed throughout non-acrocentric human autosomes. This is the ®rst, large scale analysis of genomic alterations in human HCC using microsatellite markers. The data, collected on a single genetic map, allow precise estimation of the relative frequency and accurate positioning of each chromosomal change.
Results

Allelotyping of HCC
We examined DNAs isolated from 120 paired HCC and adjacent non tumorous liver tissues for allelic imbalances. Serological studies revealed that among the 116 patients tested for hepatitis B virus (HBV) markers, 83 were positive for hepatitis B surface antigen (HBsAg) and among the 42 patients analysed for hepatitis C virus (HCV) markers, 19 were HCV Ab positive, including four that were also positive for HBsAg. HBV DNA integration was observed in 33 HCC samples (31 among the HBsAg positive patients and two among the HBsAg negative).
Allelic imbalances were assayed by PCR with primer pairs that¯ank highly polymorphic CA microsatellites. We selected a panel of 195 representative markers (Table 1) mapping to 39 non-acrocentric autosomal arms and spanning a total distance of 3432 cM with 171 intervals, which corresponds to an average marker distance of 20 cM (range, 15 ± 22 cM). The mean homozygosity of the microsatellite markers was 27%, a value which is comparable to that in the literature (Gyapay et al., 1994) . On average, 73 tumors out of the 120 analysed were informative.
A dierence in the relative allele intensity ratios between tumor DNA and normal DNA in an informative tumor/normal pair was scored as loss of heterozygosity (see Materials and methods Table 2 . Among them, the highest rates of LOH were observed for speci®c loci on chromosome arms 2q36 ± q37 (29%), 4q35 (40%), 6q27 (36%), 7p15 (30%), 8p23 (42%), 13q12 ± q13 (30 ± 32%), 16q23 ± q24 (28%) and 17p13 (33%). The LOH detected at locus D8S277 in 8p23 with a frequency of 42% of 97 informative HCCs corresponds to the most frequent genetic alteration in our study. A number of chromosomal subregions found to be aected in our analysis had been already reported on chromosome arms 1p, 4q, 6q, 8p, 10q, 13q, 16p, 16q, 17p (Buetow et al., 1989; De Souza et al., 1995; Emi et al., 1992; Fujimori et al., 1991; Tsuda et al., 1990; Wang and Rogler, 1988; Yeh et al., 1994) . In addition, we detected LOH in loci that had never been involved in previous studies, notably in 1q22 ± q23, 1q42 ± q43, 2q36 ± q37, 7p15 ± p22, 7q33 ± q34, 8q23 ± q24, 9p12 ± p14, 9q34 ± qter, 14q32 and 17q24 ± qter. We were able to de®ne two noncontinuous signi®cant regions of LOH on 1p (at 1p21 ± p22 and p36) and three on 4q (at 4q12 ± q21, q22 ± q24 and q35) indicating that several genes on chromosomes 1 and 4 may be targets of genetic alterations. On 8p and 13q, frequent LOH was found spanning a large region of three contiguous markers (D8S277, D8S550 and D8S550 and D8S282 for 8p, D13S171, D13S284 and D13S170 for 13q) suggesting the presence of more than one tumor suppressor gene in these regions.
Genetic alterations on individual chromosomal arms and clinicopathological data
As markers were distributed with equal intervals on each chromosome, the frequency of LOH per chromosome arm was analysed (Table 3) . Average percent LOH per chromosomal arm was 24.9+12.7%. In total, 119 out of the 120 HCC cases analysed were informative for at least one locus on each of the 39 chromosome arms. Allelic changes occurring at a frequency of 25% (average) or more of informative HCC cases were on 1p (51%), 1q (44%), 2q (35%), 4q (52%), 6q (48%), 7p (28%), 7q (28%), 8p (40%), 8q (26%), 9p (33%), 9q (43%), 10q (25%), 13q (53%), 14q (34%), 16p (36%), 16q (31%), 17p (34%) and 17q (31%). Among the chromosome arms showing the highest frequencies of microsatellite abnormalities (531%), eight (1p, 4q, 6q, 8p, 13q, 16p, 16q and 17p) had been implicated in previous studies (Buetow et al., 1989; Emi et al., 1992; Fujimori et al., 1991;  Tsuda et al., 1990; Wang and Rogler, 1988; Yeh et al., 1994) and six (1q, 2q, 9p, 9q, 14q and 17q) appear as new candidates for the search of tumor suppressor genes.
We were then interested in exploring a possible correlation between clinicopathological characteristics of the tumors and LOH. Because the limited number of samples showing LOH at each individual locus and for which clinicopathological parameters were available could not confer any signi®cant statistical value, we performed the analysis at the level of each chromosomal arm. The data are summarized in Table 3 . None of the chromosome arm alteration was statistically correlated with positive serum markers (HBsAg or HCVAb) for hepatitis virus infections. Although the relationship between LOH and the tumor stage could not be statistically evaluated because of the low number of early tumors, a tendency towards frequent LOH on 1p and 1q was observed in small HCCs classi®ed as T1 (respectively four and ®ve of ten tumors). On the contrary, at this tumor stage, few changes were noted on 2q, 6q, 7q, 8q, 14q, 16pq and 17pq (0 ± 1 of ten tumors). Allelic imbalance on 16p and 17p appeared relatively frequently in invasive tumors having intrahepatic metastasis or portal vein invasions compared to non-invasive tumors (3 ± 4/12 vs 1/13 tumors). Pathological information of the adjacent non-tumorous liver counterparts were obtained from 66 cases, 35 of which displayed chronic hepatitis (CH) lesions and the remainder (31) liver cirrhosis (LC). No statistically signi®cative correlation was observed between the presence of genetic alterations on a particular chromosomal arm and the pathological state of the non tumorous liver. However, the frequency of LOH observed concomitantly on both arms 1p and 13q, 1p and 8p as well as 6q and 13q were signi®cantly higher in tumors arising from CH than LC (the number of HCCs with CH vs LC showing LOH in above combinations were 16 vs 5, 16 vs 6, and 14 vs 3 respectively).
Discussion
Primary liver tumors, like other solid tumors in humans, most likely arise through a cascade of genetic events involving oncogenes and tumor suppressor genes that results in decreasing stability of the genome and ultimately leads to the malignant phenotype. The methods used here, that allowed an accurate and complete scan of 120 hepatocellular carcinoma genomes for allelic imbalance, are of great value for locating candidate genes implicated in liver cancer development.
In agreement with previous studies (Buetow et al., 1989; De Souza et al., 1995; Emi et al., 1992; Fujimori et al., 1991; Tsuda et al., 1990; Yeh et al., 1994) , we detected frequent changes in allelic dosage at particular regions of chromosomes 1p, 4q, 6q, 8p, 13q, 16p, 16q and 17p. In addition we provide evidence for`new loci' exhibiting a high rate of LOH on chromosome arms 1q, 2q, 9p, 9q, 14q and 17q. Genetic alterations of these regions have been observed in many other malignancies including breast cancers, small-cell lung carcinomas, prostate cancers, renal cell carcinomas, malignant melanomas or meningiomas, suggesting that tumor suppressor genes implicated in a wide spectrum of tumors may aect HCC progression (Cox et al., 1995; Hearly et al., 1995; Ranford et al., 1995; Takahashi et al., 1995; .
The highest ratio of LOH for an individual marker was detected at the D8S277 locus on 8p23 (42% of informative cases). Recently, a candidate tumor suppressor gene, the PRLTS gene located in 8p21 ± p22, has been cloned and found to be mutated in a minority of HCCs and colorectal carcinomas . Our data indicate that a more telomeric locus, which shows a higher frequency of LOH compared to 8p21 ± p22 markers, is likely to contain a second candidate tumor suppressor gene for HCC. On the long arm of chromosome 4, we were able to de®ne three non contiguous regions of LOH in 4q12, 4q22 ± q24 and 4q35. Chromosomal alterations at 4q are of great interest because they represent a unique trait in HCC. Buetow et al. (1989) reported LOH at the albumin gene locus (4q11 ± q12) in all of ®ve informative HCCs, indicating that a tumor suppressor gene might lie in this region. Our data suggest that alterations in two additional loci on chromosome 4q may play a role in liver carcinogenesis. Because chromosome 4q contains genes encoding growth factors or genes expressed predominantly in the liver such as albumin, alcohol dehydrogenase (ADH3), ®brinogen and UDP-glucuronyl-transferase, the deletion of this region might profoundly alter cell growth conditions and hepatocyte functions. The most frequent chromosome arm deletion was observed in 13q (53% of informative tumors). Deletions were encompassing a large region of 13q (13q12 ± q32) which harbors the RB and BRCA2 tumor suppressor genes (Friend et al., 1986; Wooster et al., 1995; Zhang et al., 1994) . However, the involvement of these two genes in HCC remains to be established. On 6q26 ± 27, a candidate tumor suppressor gene, the M6P/IGFIIR gene, has recently been shown to be mutated in 25% of HCCs (3/12) with a concomitant loss of the second allele (De Souza et al., 1995) . Including this locus, we found frequent LOH with markers spanning a large region of 6q (Table 3 and data not shown), therefore a ®ne mapping will be required to determine whether or not other HCC-associated tumor suppressor genes exist on 6q.
No obvious correlation was found between the presence of LOH on particular chromosomal arms and either viral hepatitis infections or integration of HBV. The LOH on 1p and 1q seem to be more frequent in small tumors, however, conclusive value should be obtained by increasing the number of samples or by analysing tumors at dierent developmental stages, such as so-called`nodules in nodules'. Interestingly, histological analysis of the adjacent non tumorous livers revealed that the frequency of deletions at combined chromosomal regions (1p, 6q, 8p and 13q) was signi®cantly higher in HCCs arising on chronic hepatitis lesions than in HCCs developing on liver cirrhosis. It is thus tempting to hypothesize that when hepatocytes accumulate allelic changes under regenerative pressure, some combined chromosomal arm losses may constitute a`short-cut' towards malignancy.
Genetic alterations frequently detected in human cancers include regional ampli®cation of chromosome arms. In liver cancer, multiplication of a large region at 8q24 (Fujiwara et al., 1993) and of the distal part of chromosome 1p Yeh et al., 1994) have been previously reported. Our recent comparative genomic hybridization analysis of HCC has revealed frequent increase in the copy number of chromosomal regions at 8q22 ± 24, 1q11 ± 25, and, to a lesser extent, at chromosomes 6p and 17q (Marchio et al., 1997) . These data suggest that a fraction of allelic imbalances in the loci described in the present study includes regional ampli®cations. A more detailed characterization of these putative ampli®ed regions will be necessary in the future.
In summary, this study revealed the existence of a multiplicity of genetic alterations that may play a signi®cant role during HCC development. These observations should be useful for attempts to characterize the critical liver cancer tumor suppressor genes. In particular, we plan to re®ne further the regions of loss on 8p with ®ne structure mapping and positional cloning to identify the candidate gene(s) in this area of interest.
Materials and methods
Patients and DNA preparation
One hundred and twenty primary HCCs and adjacent noncancerous liver tissues were obtained from patients of various geographical origin who had undergone surgery. Frozen tissues were crushed and high molecular weight genomic DNAs were isolated as described previously (Nagai et al., 1994) . Hepatitis B virus (HBV) integration was examined by Southern blotting using a 32 P-labeled HBV DNA probe. The presence of HBsAg was analysed using standard solid-phase radioimmunoassays (Abbott Laboratories). Serum anti-HCV Ab was measured by an enzyme-linked immunosorbent assay. TNM classi®cation was applied to determine the tumor stage for each tumor (Hermanek and Sobin, 1987) .
Microsatellite repeat ampli®cation analysis
A total of 120 HCCs were assayed for LOH by PCR with 195 selected primer pairs, designated as`panel A markers' from the collection of GeÂ neÂ thon human genetic linkage map 1993 ± 1994 (Gyapay et al., 1994) . Each step of ampli®cation, gel analysis and hybridization with (CA)n oligo probes were performed according to the large scale protocol as described in Vignal et al. (1993) . PCR was performed in a ®nal 50 ml reaction volume including 50 ng of genomic DNA, 50 pmol of each primer, 1.25 mM dNTPs, 1 unit of Taq polymerase and 16PCR buer (10 mM Tris (pH 9), 50 mM KCl, 1.5 mM MgCl 2 , 0.1% Triton X-100 and 0.01% gelatin). Distribution of the various reagents was carried out using Hamilton AT plus robotics equipment (Hamilton, Switzerland). A`hot start' procedure was used in which the Taq polymerase was added after an initial denaturation step of 5 min at 968C. Ampli®cation was carried out during 35 cycles of denaturation (948C for 40 s) and annealing (558C for 30 s). At the end of the last cycle, samples were incubated at 728C for 2 min for complete elongation. Six to eight dierent marker products from the same individual were coprecipitated. Each coprecipitate was then dissolved in 5 ml of TE and mixed with 10 ml of deionized formamide and 2.5 ml of loading mix containing xylene cyanol blue and 50% sucrose. Samples were separated on 6% polyacrylamide gel in 8.3 M urea and then transferred onto nylon membrane by capillary blotting. Two of three dierent primers whose products did not overlap in size were selected, 32 P end-labeled and used as hybridization probes. The membranes were serially hybridized at 428C several times using standard procedures.
Assessment of loss of heterozygostiy
The signal intensity of each allele ampli®ed from tumor DNA was compared with that from the corresponding normal counterpart DNA. Two reviewers (HN, PP) evaluated the autoradiograms visually. Representative examples of autoradiograms showing AI are illustrated in Figure 1 . In a great majority of AI cases, we observed a D12S367 D9S164  D2S286  TN  TN  TN   D16S422  D1S199  D7S493  TN  TN  TN   D17S787  D17S787  TN  TN   T53  T61  T32   T48  T58  T20   T28  T18¨ marked reduction in the intensity of one allele in tumor DNA compared to normal DNA, consistent with allelic loss (Figure 1a) . The ®nding that a complete loss of one of the bands in tumor DNA track was rarely observed likely re¯ects the presence of normal, non parenchymal cells in tumor samples. A minor form of microsatellite abnormality in tumor DNA was allelic imbalance associated with increased signal intensity of one allele (Figure 1a , T20) which may be interpreted as allelic gain Yeh et al., 1994) . Although the amount of the tumor and corresponding normal DNAs for PCR reaction was adjusted by repeated PCR experiments, we cannot ®rmly exclude that the dosage change of a given allele in HCC was due to gene ampli®cation rather than allelic loss. We thus considered allelic imbalance, that includes both allelic loss and gain, as a representative value for loss of heterozygosity (LOH). Homozygotes were declared`not informative' (Figure 1b) .
Statistical analysis
Relationships between clinicopathological characteristics and observed LOH were evaluated using w 2 test. The level of statistical signi®cance was set at P50.05.
